DE3117756C2 - - Google Patents

Info

Publication number
DE3117756C2
DE3117756C2 DE3117756A DE3117756A DE3117756C2 DE 3117756 C2 DE3117756 C2 DE 3117756C2 DE 3117756 A DE3117756 A DE 3117756A DE 3117756 A DE3117756 A DE 3117756A DE 3117756 C2 DE3117756 C2 DE 3117756C2
Authority
DE
Germany
Prior art keywords
theophylline
tablet
tablets
hours
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3117756A
Other languages
German (de)
English (en)
Other versions
DE3117756A1 (de
Inventor
Stephen T. David
Dana Brooks
Claude E. Evansville Ind. Us Gallian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE3117756A1 publication Critical patent/DE3117756A1/de
Application granted granted Critical
Publication of DE3117756C2 publication Critical patent/DE3117756C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19813117756 1980-05-06 1981-05-05 "theophyllin-tablette" Granted DE3117756A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (2)

Publication Number Publication Date
DE3117756A1 DE3117756A1 (de) 1982-04-29
DE3117756C2 true DE3117756C2 (fr) 1992-11-26

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813117756 Granted DE3117756A1 (de) 1980-05-06 1981-05-05 "theophyllin-tablette"

Country Status (17)

Country Link
AT (1) AT380789B (fr)
AU (1) AU549299B2 (fr)
CA (1) CA1165241A (fr)
CY (1) CY1368A (fr)
DE (1) DE3117756A1 (fr)
DK (1) DK155976C (fr)
FI (1) FI811356L (fr)
FR (1) FR2484253A1 (fr)
GB (1) GB2078518B (fr)
HK (1) HK4288A (fr)
IE (1) IE51157B1 (fr)
IT (1) IT1209867B (fr)
KE (1) KE3722A (fr)
LU (1) LU83342A1 (fr)
NL (1) NL8102168A (fr)
SE (1) SE452550B (fr)
SG (1) SG30987G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (fr) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
AT380789B (de) 1986-07-10
SG30987G (en) 1987-07-17
ATA202081A (de) 1985-12-15
DK155976B (da) 1989-06-12
HK4288A (en) 1988-01-29
CA1165241A (fr) 1984-04-10
AU549299B2 (en) 1986-01-23
FR2484253B1 (fr) 1983-06-03
FR2484253A1 (fr) 1981-12-18
AU7020581A (en) 1981-11-12
LU83342A1 (fr) 1982-01-20
DK155976C (da) 1989-10-30
NL8102168A (nl) 1981-12-01
IE810989L (en) 1981-11-06
KE3722A (en) 1987-04-30
SE452550B (sv) 1987-12-07
DE3117756A1 (de) 1982-04-29
CY1368A (en) 1987-08-07
GB2078518A (en) 1982-01-13
IE51157B1 (en) 1986-10-15
GB2078518B (en) 1984-04-11
FI811356L (fi) 1981-11-07
IT1209867B (it) 1989-08-30
IT8148406A0 (it) 1981-05-06
SE8102814L (sv) 1981-11-07
DK200181A (da) 1981-11-07

Similar Documents

Publication Publication Date Title
DE3329265C2 (fr)
DE1617374C2 (de) Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung
DE3309516C2 (fr)
DE60132723T2 (de) Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
DE69821553T2 (de) Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat
DE60207383T2 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
DE60225331T2 (de) Pharmazeutische zusammensetzungen mit metformin und glibenclamid zur behandlung von diabetes mellitus typ ii
DE3435325A1 (de) Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
US4465660A (en) Sustained release tablet containing at least 95 percent theophylline
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE2414868A1 (de) Arzneimittel und verfahren zu seiner herstellung
DE2813480A1 (de) Arzneimittel-depotpraeparat vom mehrfacheinheitsdosen-typ
DE3435040A1 (de) Pharmazeutische zusammensetzung, geeignet zur behandlung von hang-over-symptomen
DE3390114C2 (fr)
EP0250648B1 (fr) Préparation pharmaceutique pour la libération retardée de l'ibuprofène
AT389226B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE2823174A1 (de) Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
DE3719818A1 (de) Pharmazeutische zusammensetzungen
US4547358A (en) Sustained release tablet containing at least 95 percent theophylline
DE3117756C2 (fr)
DE2359128A1 (de) Arzneimittel auf basis von lisurid und dessen physiologisch vertraeglichen salzen
DE2758942A1 (de) Kautabletten mit einem gehalt an erythromycin
DE3528481A1 (de) Neues pharmazeutisches praeparat
DE3040042A1 (de) Pharmazeutische zubereitung des tiaramids oder seiner pharmazeutisch vertraeglichen salze
CH646605A5 (en) Theophylline tablet with delayed release of active substance

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA

8128 New person/name/address of the agent

Representative=s name: KINZEBACH, W., DIPL.-CHEM. DR.PHIL. RIEDL, P., DIP

D2 Grant after examination
8364 No opposition during term of opposition